Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Molecular Typing of Candida glabrata.

Gabaldón T, Gómez-Molero E, Bader O.

Mycopathologia. 2019 Oct 15. doi: 10.1007/s11046-019-00388-x. [Epub ahead of print] Review.

PMID:
31617105
2.

Proteotyping of Clostridioides difficile as Alternate Typing Method to Ribotyping Is Able to Distinguish the Ribotypes RT027 and RT176 From Other Ribotypes.

Emele MF, Joppe FM, Riedel T, Overmann J, Rupnik M, Cooper P, Kusumawati RL, Berger FK, Laukien F, Zimmermann O, Bohne W, Groß U, Bader O, Zautner AE.

Front Microbiol. 2019 Sep 10;10:2087. doi: 10.3389/fmicb.2019.02087. eCollection 2019.

3.

Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants.

Petersen J, Staab J, Bader O, Buhl T, Ivetic A, Meyer T.

Mol Immunol. 2019 Oct;114:30-40. doi: 10.1016/j.molimm.2019.07.008. Epub 2019 Jul 20.

PMID:
31336247
4.

Differentiation of Campylobacter fetus Subspecies by Proteotyping.

Emele MF, Karg M, Hotzel H, Bloois LG, Groß U, Bader O, Zautner AE.

Eur J Microbiol Immunol (Bp). 2019 May 20;9(2):62-71. doi: 10.1556/1886.2019.00006. eCollection 2019 Jun 3.

5.

Proteotyping as alternate typing method to differentiate Campylobacter coli clades.

Emele MF, Možina SS, Lugert R, Bohne W, Masanta WO, Riedel T, Groß U, Bader O, Zautner AE.

Sci Rep. 2019 Mar 12;9(1):4244. doi: 10.1038/s41598-019-40842-w.

6.

Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations.

Carreté L, Ksiezopolska E, Gómez-Molero E, Angoulvant A, Bader O, Fairhead C, Gabaldón T.

Front Microbiol. 2019 Feb 12;10:112. doi: 10.3389/fmicb.2019.00112. eCollection 2019.

7.

High diversity of Candida glabrata in a tertiary hospital-Mwanza, Tanzania.

Mushi MF, Gross U, Mshana SE, Bader O.

Med Mycol. 2019 Oct 1;57(7):914-917. doi: 10.1093/mmy/myy151.

PMID:
30597052
8.

Rapid and Sensitive Detection of Azole-Resistant Aspergillus fumigatus by Tandem Repeat Loop-Mediated Isothermal Amplification.

Yu LS, Rodriguez-Manzano J, Malpartida-Cardenas K, Sewell T, Bader O, Armstrong-James D, Fisher MC, Georgiou P.

J Mol Diagn. 2019 Mar;21(2):286-295. doi: 10.1016/j.jmoldx.2018.10.004. Epub 2018 Dec 4.

9.

Disseminated cryptococcosis in a HIV-negative patient: Case report of a newly diagnosed hypertensive adult presenting with hemiparesis.

Wilson RM, Moremi N, Mushi MF, Bader O, Ngoya PS, Desderius BM, Rambau P, Kabangila R, Groß U, Mshana SE.

Med Mycol Case Rep. 2018 Jul 12;22:4-7. doi: 10.1016/j.mmcr.2018.07.003. eCollection 2018 Dec.

10.

Virulence and susceptibility patterns of clinical Candida spp. isolates from a tertiary hospital, Tanzania.

Mushi MF, Bader O, Bii C, Groß U, Mshana SE.

Med Mycol. 2018 Oct 31. doi: 10.1093/mmy/myy107. [Epub ahead of print]

PMID:
30380077
11.

Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients.

Postina P, Skladny J, Boch T, Cornely OA, Hamprecht A, Rath PM, Steinmann J, Bader O, Miethke T, Dietz A, Merker N, Hofmann WK, Buchheidt D, Spiess B.

Front Microbiol. 2018 Mar 27;9:555. doi: 10.3389/fmicb.2018.00555. eCollection 2018.

12.

Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.

Idelevich EA, Groß U, Becker K, Bader O.

Diagn Microbiol Infect Dis. 2018 May;91(1):52-54. doi: 10.1016/j.diagmicrobio.2018.01.003. Epub 2018 Jan 9.

PMID:
29422272
13.

Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence.

Richardson JP, Mogavero S, Moyes DL, Blagojevic M, Krüger T, Verma AH, Coleman BM, De La Cruz Diaz J, Schulz D, Ponde NO, Carrano G, Kniemeyer O, Wilson D, Bader O, Enoiu SI, Ho J, Kichik N, Gaffen SL, Hube B, Naglik JR.

mBio. 2018 Jan 23;9(1). pii: e02178-17. doi: 10.1128/mBio.02178-17.

14.

Patterns of Genomic Variation in the Opportunistic Pathogen Candida glabrata Suggest the Existence of Mating and a Secondary Association with Humans.

Carreté L, Ksiezopolska E, Pegueroles C, Gómez-Molero E, Saus E, Iraola-Guzmán S, Loska D, Bader O, Fairhead C, Gabaldón T.

Curr Biol. 2018 Jan 8;28(1):15-27.e7. doi: 10.1016/j.cub.2017.11.027. Epub 2017 Dec 14.

15.

Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Dudakova A, Spiess B, Tangwattanachuleeporn M, Sasse C, Buchheidt D, Weig M, Groß U, Bader O.

Clin Microbiol Rev. 2017 Oct;30(4):1065-1091. doi: 10.1128/CMR.00095-16. Review.

16.

Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa.

Mushi MF, Bader O, Taverne-Ghadwal L, Bii C, Groß U, Mshana SE.

J Oral Microbiol. 2017 Jun 21;9(1):1317579. doi: 10.1080/20002297.2017.1317579. eCollection 2017. Review.

17.

Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.

Rößler S, Bader O, Stölzel F, Sommer U, Spiess B, Geibel S, Buchheidt D, Groß U, Baretton G, Jacobs E, Ostrosky-Zeichner L.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00270-17. doi: 10.1128/AAC.00270-17. Print 2017 Aug.

18.

Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?

Hamprecht A, Morio F, Bader O, Le Pape P, Steinmann J, Dannaoui E.

Mycopathologia. 2018 Feb;183(1):151-160. doi: 10.1007/s11046-017-0162-4. Epub 2017 Jun 26. Review.

PMID:
28653258
19.

Prevalence of pregnancy-relevant infections in a rural setting of Ghana.

Völker F, Cooper P, Bader O, Uy A, Zimmermann O, Lugert R, Groß U.

BMC Pregnancy Childbirth. 2017 Jun 6;17(1):172. doi: 10.1186/s12884-017-1351-3.

20.

Oral findings and dental behaviour before and after liver transplantation - a single-centre cross-sectional study.

Kauffels A, Schmalz G, Kollmar O, Slotta JE, Weig M, Groß U, Bader O, Ziebolz D.

Int Dent J. 2017 Aug;67(4):244-251. doi: 10.1111/idj.12290. Epub 2017 Mar 10.

PMID:
28295299
21.

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ.

Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.

PMID:
27989379
22.

Diversity and Antifungal Drug Susceptibility of Cryptococcus Isolates in Thailand.

Worasilchai N, Tangwattanachuleeporn M, Meesilpavikkai K, Folba C, Kangogo M, Groß U, Weig M, Bader O, Chindamporn A.

Med Mycol. 2017 Aug 1;55(6):680-685. doi: 10.1093/mmy/myw130.

PMID:
27915307
23.

Subtyping of Campylobacter jejuni ssp. doylei Isolates Using Mass Spectrometry-based PhyloProteomics (MSPP).

Zautner AE, Lugert R, Masanta WO, Weig M, Groß U, Bader O.

J Vis Exp. 2016 Oct 30;(116). doi: 10.3791/54165.

24.

Fungal Species Identification by MALDI-ToF Mass Spectrometry.

Bader O.

Methods Mol Biol. 2017;1508:323-337.

PMID:
27837514
25.

Prevalence of azole-resistant Aspergillus fumigatus in the environment of Thailand.

Tangwattanachuleeporn M, Minarin N, Saichan S, Sermsri P, Mitkornburee R, Groß U, Chindamporn A, Bader O.

Med Mycol. 2017 Jun 1;55(4):429-435. doi: 10.1093/mmy/myw090.

PMID:
27664994
26.

Erratum to: Identification of Stachybotrys spp. by MALDI-TOF mass spectrometry.

Ulrich S, Biermaier B, Bader O, Wolf G, Straubinger RK, Didier A, Sperner B, Schwaiger K, Gareis M, Gottschalk C.

Anal Bioanal Chem. 2016 Nov;408(27):7879. Epub 2016 Sep 9. No abstract available.

PMID:
27613014
27.
28.

Identification of Stachybotrys spp. by MALDI-TOF mass spectrometry.

Ulrich S, Biermaier B, Bader O, Wolf G, Straubinger RK, Didier A, Sperner B, Schwaiger K, Gareis M, Gottschalk C.

Anal Bioanal Chem. 2016 Nov;408(27):7565-7581. Epub 2016 Jul 30. Erratum in: Anal Bioanal Chem. 2016 Nov;408(27):7879.

PMID:
27475444
29.

High Oral Carriage of Non-albicans Candida spp. among HIV-infected individuals.

Mushi MF, Mtemisika CI, Bader O, Bii C, Mirambo MM, Groß U, Mshana SE.

Int J Infect Dis. 2016 Aug;49:185-8. doi: 10.1016/j.ijid.2016.07.001. Epub 2016 Jul 8.

30.

Attending to emotions is sharing of emotions - A multidisciplinary perspective to social attention and emotional sharing. Comment on Zahavi and Rochat (2015).

Bader O.

Conscious Cogn. 2016 May;42:382-395. doi: 10.1016/j.concog.2016.04.012. Epub 2016 May 3. Review.

PMID:
27152930
31.

Candidalysin is a fungal peptide toxin critical for mucosal infection.

Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, Höfs S, Gratacap RL, Robbins J, Runglall M, Murciano C, Blagojevic M, Thavaraj S, Förster TM, Hebecker B, Kasper L, Vizcay G, Iancu SI, Kichik N, Häder A, Kurzai O, Luo T, Krüger T, Kniemeyer O, Cota E, Bader O, Wheeler RT, Gutsmann T, Hube B, Naglik JR.

Nature. 2016 Apr 7;532(7597):64-8. doi: 10.1038/nature17625. Epub 2016 Mar 30.

32.

Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation.

Mössner R, Diering N, Bader O, Forkel S, Overbeck T, Gross U, Grimbacher B, Schön MP, Buhl T.

Clin Infect Dis. 2016 Apr 1;62(7):951-3. doi: 10.1093/cid/ciw020. Epub 2016 Jan 19. No abstract available.

PMID:
26787170
33.

Towards proteomic species barcoding of fungi - An example using Scedosporium/Pseudallescheria complex isolates.

Bernhard M, Zautner AE, Steinmann J, Weig M, Groß U, Bader O.

Fungal Biol. 2016 Feb;120(2):162-5. doi: 10.1016/j.funbio.2015.07.001. Epub 2015 Jul 17.

PMID:
26781372
34.

SMRT sequencing of the Campylobacter coli BfR-CA-9557 genome sequence reveals unique methylation motifs.

Zautner AE, Goldschmidt AM, Thürmer A, Schuldes J, Bader O, Lugert R, Groß U, Stingl K, Salinas G, Lingner T.

BMC Genomics. 2015 Dec 21;16:1088. doi: 10.1186/s12864-015-2317-3.

35.

Aspergillus oerlinghausenensis, a new mould species closely related to A. fumigatus.

Houbraken J, Weig M, Groß U, Meijer M, Bader O.

FEMS Microbiol Lett. 2016 Feb;363(3). pii: fnv236. doi: 10.1093/femsle/fnv236. Epub 2015 Dec 13.

PMID:
26667219
36.

The Reduction in Antibiotic Use in Hospitals.

Scholze K, Wenke M, Schierholz R, Groß U, Bader O, Zimmermann O, Lemmen S, Ortlepp JR.

Dtsch Arztebl Int. 2015 Oct 16;112(42):714-21. doi: 10.3238/arztebl.2015.0714.

37.

Proteomic analysis of hyperadhesive Candida glabrata clinical isolates reveals a core wall proteome and differential incorporation of adhesins.

Gómez-Molero E, de Boer AD, Dekker HL, Moreno-Martínez A, Kraneveld EA, Ichsan, Chauhan N, Weig M, de Soet JJ, de Koster CG, Bader O, de Groot PW.

FEMS Yeast Res. 2015 Dec;15(8). pii: fov098. doi: 10.1093/femsyr/fov098. Epub 2015 Nov 5.

PMID:
26546455
38.

Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.

Kangogo M, Bader O, Boga H, Wanyoike W, Folba C, Worasilchai N, Weig M, Groß U, Bii CC.

Mycoses. 2015 Nov;58(11):665-70. doi: 10.1111/myc.12411. Epub 2015 Sep 25.

PMID:
26404188
39.

Mass Spectrometry-based PhyloProteomics (MSPP): A novel microbial typing Method.

Zautner AE, Masanta WO, Weig M, Groß U, Bader O.

Sci Rep. 2015 Aug 25;5:13431. doi: 10.1038/srep13431.

40.

Environmental isolates of azole-resistant Aspergillus fumigatus in Germany.

Bader O, Tünnermann J, Dudakova A, Tangwattanachuleeporn M, Weig M, Groß U.

Antimicrob Agents Chemother. 2015 Jul;59(7):4356-9. doi: 10.1128/AAC.00100-15. Epub 2015 May 4.

41.

One small step for a yeast--microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutation.

Brunke S, Seider K, Fischer D, Jacobsen ID, Kasper L, Jablonowski N, Wartenberg A, Bader O, Enache-Angoulvant A, Schaller M, d'Enfert C, Hube B.

PLoS Pathog. 2014 Oct 30;10(10):e1004478. doi: 10.1371/journal.ppat.1004478. eCollection 2014 Oct.

42.

Yeast on-target lysis (YOTL), a procedure for making auxiliary mass spectrum data sets for clinical routine identification of yeasts.

Bernhard M, Weig M, Zautner AE, Groß U, Bader O.

J Clin Microbiol. 2014 Dec;52(12):4163-7. doi: 10.1128/JCM.02128-14. Epub 2014 Sep 17.

43.

[Azole resistance in Aspergillus fumigatus - epidemiology and detection in immunocompromised patients in Germany].

Buchheidt D, Spiess B, Cornely OA, Vehreschild MJ, Hamprecht A, Rath PM, Steinmann J, Groß U, Bader O, Lauten M, Reinwald M, Hofmann WK.

Dtsch Med Wochenschr. 2014 Jun;139(25-26):1373-6. doi: 10.1055/s-0034-1370130. Epub 2014 Jun 10. Review. German. No abstract available.

PMID:
24914515
44.

Looking into the virulence of Candida parapsilosis: a diagnostic perspective.

Bader O.

Virulence. 2014 May 15;5(4):457-9. doi: 10.4161/viru.28955. Epub 2014 Apr 23. No abstract available.

45.

[Incidence of Candidaemia Following Abdominal Surgery in German Hospitals].

Kuhns M, Rosenberger A, Bader O, Reichard U, Gross U, Weig M.

Zentralbl Chir. 2015 Dec;140(6):617-23. doi: 10.1055/s-0033-1350814. Epub 2013 Nov 15. German.

PMID:
24241950
46.

Discrimination of multilocus sequence typing-based Campylobacter jejuni subgroups by MALDI-TOF mass spectrometry.

Zautner AE, Masanta WO, Tareen AM, Weig M, Lugert R, Groß U, Bader O.

BMC Microbiol. 2013 Nov 7;13:247. doi: 10.1186/1471-2180-13-247.

47.

Prevalence and antifungal susceptibility of Cryptococcus neoformans isolated from pigeon excreta in Chon Buri Province, Eastern Thailand.

Tangwattanachuleeporn M, Somparn P, Poolpol K, Gross U, Weig M, Bader O.

Med Mycol J. 2013;54(3):303-7.

48.

Soybean toxin (SBTX) impairs fungal growth by interfering with molecular transport, carbohydrate/amino acid metabolism and drug/stress responses.

Morais JK, Bader O, Weig M, Oliveira JT, Arantes MR, Gomes VM, Da Cunha M, Oliveira HD, Sousa DO, Lourencao AL, Vasconcelos IM.

PLoS One. 2013 Jul 22;8(7):e70425. doi: 10.1371/journal.pone.0070425. Print 2013.

49.

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.

Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, Held J, Peter S, Schumacher U, Buchheidt D, Tintelnot K, Groß U; MykoLabNet-D Partners.

Antimicrob Agents Chemother. 2013 Aug;57(8):3513-7. doi: 10.1128/AAC.00167-13. Epub 2013 May 13.

50.

Adhesins in human fungal pathogens: glue with plenty of stick.

de Groot PW, Bader O, de Boer AD, Weig M, Chauhan N.

Eukaryot Cell. 2013 Apr;12(4):470-81. doi: 10.1128/EC.00364-12. Epub 2013 Feb 8. Review.

Supplemental Content

Support Center